Csenge Advisory Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $562K | Buy |
+5,106
| New | +$562K | 0.03% | 398 |
|
|
2025
Q1 | – | Sell |
-2,442
| Closed | -$226K | – | 692 |
|
|
2024
Q4 | $226K | Sell |
2,442
-3,197
| -57% | -$295K | 0.01% | 629 |
|
|
2024
Q3 | $479K | Sell |
5,639
-1,504
| -21% | -$128K | 0.03% | 433 |
|
|
2024
Q2 | $490K | Sell |
7,143
-1,288
| -15% | -$88.4K | 0.03% | 407 |
|
|
2024
Q1 | $618K | Sell |
8,431
-5,932
| -41% | -$435K | 0.03% | 380 |
|
|
2023
Q4 | $1.16M | Buy |
14,363
+547
| +4% | +$44.3K | 0.07% | 210 |
|
|
2023
Q3 | $1.04M | Buy |
13,816
+1,219
| +10% | +$91.4K | 0.07% | 205 |
|
|
2023
Q2 | $971K | Buy |
12,597
+1,674
| +15% | +$129K | 0.07% | 217 |
|
|
2023
Q1 | $906K | Buy |
10,923
+379
| +4% | +$31.4K | 0.07% | 226 |
|
|
2022
Q4 | $905K | Buy |
10,544
+1,575
| +18% | +$135K | 0.07% | 228 |
|
|
2022
Q3 | $553K | Sell |
8,969
-574
| -6% | -$35.4K | 0.05% | 313 |
|
|
2022
Q2 | $590K | Buy |
9,543
+4,032
| +73% | +$249K | 0.05% | 311 |
|
|
2022
Q1 | $328K | Buy |
+5,511
| New | +$328K | 0.03% | 479 |
|
|
2018
Q4 | – | Sell |
-216
| Closed | -$15K | – | 680 |
|
|
2018
Q3 | $15K | Buy |
+216
| New | +$15K | 0.01% | 419 |
|